A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

This is a clinical trial designed to evaluate the experimental drug MK-4208/TERN-701 in healthy adult participants. The study was conducted by Terns, Inc., a subsidiary of Merck & Co., Inc. The research tested interactions between the investigational drug and various other medications including rabeprazole, midazolam, digoxin, pravastatin, montelukast, omeprazole, itraconazole, warfarin, rosuvastatin, bosentan, and quinidine. The study has been completed. The primary objective was to determine the safety and pharmacokinetics of the new drug in interaction with commonly used medications.